FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1522951000168104: Kabiven G19% (alanine 12 g / 2.566 L + arginine 8.5 g / 2.566 L + aspartic acid 2.6 g / 2.566 L + calcium chloride dihydrate 740 mg / 2.566 L + glutamic acid 4.2 g / 2.566 L + glycine 5.9 g / 2.566 L + histidine 5.1 g / 2.566 L + isoleucine 4.2 g / 2.566 L + leucine 5.9 g / 2.566 L + lysine hydrochloride 8.5 g / 2.566 L + magnesium sulfate heptahydrate 2.5 g / 2.566 L + methionine 4.2 g / 2.566 L + phenylalanine 5.9 g / 2.566 L + potassium chloride 4.5 g / 2.566 L + proline 5.1 g / 2.566 L + serine 3.4 g / 2.566 L + sodium acetate trihydrate 6.1 g / 2.566 L + sodium glycerophosphate 3.8 g / 2.566 L + threonine 4.2 g / 2.566 L + tryptophan 1.4 g / 2.566 L + tyrosine 170 mg / 2.566 L + valine 5.5 g / 2.566 L) injection [1 x 750 mL chamber] (&) (glucose 250 g / 2.566 L) injection [1 x 1.316 L chamber] (&) (soya oil 100 g / 2.566 L) injection [1 x 500 mL chamber], 3 x 2.566 L multi-chamber bags (trade product pack)


Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4519221000168113 Kabiven G19% (alanine 12 g / 2.566 L + arginine 8.5 g / 2.566 L + aspartic acid 2.6 g / 2.566 L + calcium chloride dihydrate 740 mg / 2.566 L + glutamic acid 4.2 g / 2.566 L + glycine 5.9 g / 2.566 L + histidine 5.1 g / 2.566 L + isoleucine 4.2 g / 2.566 L + leucine 5.9 g / 2.566 L + lysine hydrochloride 8.5 g / 2.566 L + magnesium sulfate heptahydrate 2.5 g / 2.566 L + methionine 4.2 g / 2.566 L + phenylalanine 5.9 g / 2.566 L + potassium chloride 4.5 g / 2.566 L + proline 5.1 g / 2.566 L + serine 3.4 g / 2.566 L + sodium acetate trihydrate 6.1 g / 2.566 L + sodium glycerophosphate 3.8 g / 2.566 L + threonine 4.2 g / 2.566 L + tryptophan 1.4 g / 2.566 L + tyrosine 170 mg / 2.566 L + valine 5.5 g / 2.566 L) injection [1 x 750 mL chamber] (&) (glucose 250 g / 2.566 L) injection [1 x 1.316 L chamber] (&) (soya oil 100 g / 2.566 L) injection [1 x 500 mL chamber], 3 x 2.566 L multi-chamber bags (trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4519231000168111 Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags en Synonym Active Case sensitive Australian Medicines Terminology module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags Is a glucose 250 g/2.566 L injection [1.316 L chamber] (&) alanine 12 g/2.566 L + arginine 8.5 g/2.566 L + aspartic acid 2.6 g/2.566 L + glutamic acid 4.2 g/2.566 L + glycine 5.9 g/2.566 L + histidine 5.1 g/2.566 L + isoleucine 4.2 g/2.566 L + leucine 5.9 g/2.566 L + lysine hydrochloride 8.5 g/2.566 L + methionine 4.2 g/2.566 L + phenylalanine 5.9 g/2.566 L + proline 5.1 g/2.566 L + serine 3.4 g/2.566 L + threonine 4.2 g/2.566 L + tryptophan 1.4 g/2.566 L + tyrosine 170 mg/2.566 L + valine 5.5 g/2.566 L + calcium chloride dihydrate 740 mg/2.566 L + sodium glycerophosphate 3.8 g/2.566 L + magnesium sulfate heptahydrate 2.5 g/2.566 L + potassium chloride 4.5 g (potassium 60 mmol)/2.566 L + sodium acetate trihydrate 6.1 g/2.566 L injection [750 mL chamber] (&) soya oil 100 g/2.566 L injection [500 mL chamber], 3 x 2.566 L multi-chamber bags true Inferred relationship Some
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags Is a trade product pack true Inferred relationship Some
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags has TP Kabiven G19% true Inferred relationship Some
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags has TPUU Kabiven G19% Intralipid 100 g/2.566 L injection, 500 mL chamber true Inferred relationship Some 1040374279
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags has TPUU Kabiven G19% Vamin 18 Novum injection, 750 mL chamber true Inferred relationship Some 931624865
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags has subpack glucose 250 g/2.566 L injection [1.316 L chamber] (&) alanine 12 g/2.566 L + arginine 8.5 g/2.566 L + aspartic acid 2.6 g/2.566 L + glutamic acid 4.2 g/2.566 L + glycine 5.9 g/2.566 L + histidine 5.1 g/2.566 L + isoleucine 4.2 g/2.566 L + leucine 5.9 g/2.566 L + lysine hydrochloride 8.5 g/2.566 L + methionine 4.2 g/2.566 L + phenylalanine 5.9 g/2.566 L + proline 5.1 g/2.566 L + serine 3.4 g/2.566 L + threonine 4.2 g/2.566 L + tryptophan 1.4 g/2.566 L + tyrosine 170 mg/2.566 L + valine 5.5 g/2.566 L + calcium chloride dihydrate 740 mg/2.566 L + sodium glycerophosphate 3.8 g/2.566 L + magnesium sulfate heptahydrate 2.5 g/2.566 L + potassium chloride 4.5 g (potassium 60 mmol)/2.566 L + sodium acetate trihydrate 6.1 g/2.566 L injection [750 mL chamber] (&) soya oil 100 g/2.566 L injection [500 mL chamber], 2.566 L multi-chamber bag true Inferred relationship Some 1273449847
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags has TPUU Kabiven G19% Glucose 250 g/2.566 L injection, 1.316 L chamber true Inferred relationship Some 623814726

Inbound Relationships Type Active Source Characteristic Refinability Group
Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags Is a True Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 3 x 2.566 L multi-chamber bags Inferred relationship Some

Reference Sets

Trade product pack reference set

Back to Start